• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

粒细胞-单核细胞吸附治疗激素抵抗溃疡性结肠炎的临床应答的预测因素。

Predictive factors of clinical response in steroid-refractory ulcerative colitis treated with granulocyte-monocyte apheresis.

机构信息

Department of Clinical Sciences, Gastrointestinal Unit, Policlinico Umberto I, University of Rome, La Sapienza, Viale del Policlinico 155, Rome 00161, Italy. Italy.

出版信息

World J Gastroenterol. 2011 Apr 14;17(14):1831-5. doi: 10.3748/wjg.v17.i14.1831.

DOI:10.3748/wjg.v17.i14.1831
PMID:21528055
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3080717/
Abstract

AIM

To identify factors predicting the clinical response of ulcerative colitis patients to granulocyte-monocyte apheresis (GMA).

METHODS

Sixty-nine ulcerative colitis patients (39 F, 30 M) dependent upon/refractory to steroids were treated with GMA. Steroid dependency, clinical activity index (CAI), C reactive protein (CRP) level, erythrocyte sedimentation rate (ESR), values at baseline, use of immunosuppressant, duration of disease, and age and extent of disease were considered for statistical analysis as predictive factors of clinical response. Univariate and multivariate logistic regression models were used.

RESULTS

In the univariate analysis, CAI (P = 0.039) and ESR (P = 0.017) levels at baseline were singled out as predictive of clinical remission. In the multivariate analysis steroid dependency [Odds ratio (OR) = 0.390, 95% Confidence interval (CI): 0.176-0.865, Wald 5.361, P = 0.0160] and low CAI levels at baseline (4 < CAI < 7) (OR = 0.770, 95% CI: 0.425-1.394, Wald 3.747, P = 0.028) proved to be effective as factors predicting clinical response.

CONCLUSION

GMA may be a valid therapeutic option for steroid-dependent ulcerative colitis patients with mild-moderate disease and its clinical efficacy seems to persist for 12 mo.

摘要

目的

确定预测溃疡性结肠炎患者对粒细胞-单核细胞吸附(GMA)临床反应的因素。

方法

69 例依赖/难治于类固醇的溃疡性结肠炎患者(39 例女性,30 例男性)接受 GMA 治疗。将类固醇依赖性、临床活动指数(CAI)、C 反应蛋白(CRP)水平、红细胞沉降率(ESR)、基线值、免疫抑制剂的使用、疾病持续时间以及年龄和疾病范围作为预测临床反应的统计分析的预测因素。使用单变量和多变量逻辑回归模型。

结果

在单变量分析中,基线时的 CAI(P = 0.039)和 ESR(P = 0.017)水平被单独确定为临床缓解的预测因素。在多变量分析中,类固醇依赖性[比值比(OR)= 0.390,95%置信区间(CI):0.176-0.865,Wald 5.361,P = 0.0160]和基线时低 CAI 水平(4 < CAI < 7)(OR = 0.770,95% CI:0.425-1.394,Wald 3.747,P = 0.028)被证明是预测临床反应的有效因素。

结论

GMA 可能是治疗轻度-中度疾病的类固醇依赖性溃疡性结肠炎患者的有效治疗选择,其临床疗效似乎可持续 12 个月。

相似文献

1
Predictive factors of clinical response in steroid-refractory ulcerative colitis treated with granulocyte-monocyte apheresis.粒细胞-单核细胞吸附治疗激素抵抗溃疡性结肠炎的临床应答的预测因素。
World J Gastroenterol. 2011 Apr 14;17(14):1831-5. doi: 10.3748/wjg.v17.i14.1831.
2
Mucosal features and granulocyte-monocyte-apheresis in steroid-dependent/refractory ulcerative colitis.类固醇依赖/难治性溃疡性结肠炎的黏膜特征与粒细胞-单核细胞分离术
Dig Liver Dis. 2006 Jun;38(6):389-94. doi: 10.1016/j.dld.2005.12.005. Epub 2006 Mar 29.
3
In patients with ulcerative colitis, adsorptive depletion of granulocytes and monocytes impacts mucosal level of neutrophils and clinically is most effective in steroid naïve patients.在溃疡性结肠炎患者中,粒细胞和单核细胞的吸附性消耗会影响中性粒细胞的黏膜水平,并且在初治患者中临床效果最为显著。
Dig Liver Dis. 2008 Sep;40(9):731-6. doi: 10.1016/j.dld.2008.02.012. Epub 2008 Apr 2.
4
Open label trial of granulocyte apheresis suggests therapeutic efficacy in chronically active steroid refractory ulcerative colitis.粒细胞单采开放标签试验表明其对慢性活动性类固醇难治性溃疡性结肠炎具有治疗效果。
World J Gastroenterol. 2005 Nov 28;11(44):7001-6. doi: 10.3748/wjg.v11.i44.7001.
5
Dose-intensified granulocyte-monocyte apheresis in therapy refractory ulcerative colitis.剂量强化粒细胞-单核细胞单采术治疗难治性溃疡性结肠炎
Artif Organs. 2015 Feb;39(2):187-92. doi: 10.1111/aor.12329. Epub 2014 Jul 1.
6
Factors associated with treatment outcome, and long-term prognosis of patients with ulcerative colitis undergoing selective depletion of myeloid lineage leucocytes: a prospective multicenter study.接受髓系谱系白细胞选择性清除治疗的溃疡性结肠炎患者的治疗结果及长期预后相关因素:一项前瞻性多中心研究
Cytotherapy. 2015 May;17(5):680-8. doi: 10.1016/j.jcyt.2015.02.007. Epub 2015 Mar 21.
7
Looking for predictive factors of clinical response to adsorptive granulocyte and monocyte apheresis in patients with ulcerative colitis: markers of response to GMA.寻找溃疡性结肠炎患者对吸附性粒细胞和单核细胞清除治疗临床反应的预测因素:对 GMA 反应的标志物。
BMC Gastroenterol. 2013 Feb 12;13:27. doi: 10.1186/1471-230X-13-27.
8
Clinical trial: five or ten cycles of granulocyte-monocyte apheresis show equivalent efficacy and safety in ulcerative colitis.临床试验:在溃疡性结肠炎中,粒细胞-单核细胞单采术的五个或十个周期显示出等效的疗效和安全性。
Aliment Pharmacol Ther. 2010 Jun;31(12):1286-95. doi: 10.1111/j.1365-2036.2010.04295.x. Epub 2010 Mar 11.
9
Efficacy and safety of granulocyte, monocyte/macrophage adsorptive in pediatric ulcerative colitis.粒细胞、单核细胞/巨噬细胞吸附疗法在儿童溃疡性结肠炎中的疗效与安全性
World J Gastroenterol. 2016 May 7;22(17):4389-96. doi: 10.3748/wjg.v22.i17.4389.
10
Ulcerative colitis with hepatitis B virus infection treated successfully by granulocyte monocyte apheresis.采用粒细胞单核细胞分离术成功治疗的合并乙型肝炎病毒感染的溃疡性结肠炎。
J Clin Apher. 2016 Dec;31(6):584-586. doi: 10.1002/jca.21450. Epub 2016 Feb 15.

引用本文的文献

1
Use of granulocyte/monocytapheresis in ulcerative colitis: A practical review from a European perspective.粒细胞/单核细胞分离术在溃疡性结肠炎中的应用:从欧洲角度的实用综述。
World J Gastroenterol. 2021 Mar 14;27(10):908-918. doi: 10.3748/wjg.v27.i10.908.
2
Has infliximab influenced the course and prognosis of acute severe ulcerative colitis?英夫利昔单抗对急性重症溃疡性结肠炎的病程及预后有影响吗?
Biologics. 2019 Apr 9;13:23-31. doi: 10.2147/BTT.S179006. eCollection 2019.
3
A multicenter retrospective study aiming to identify patients who respond well to adsorptive granulomonocytapheresis in moderately to severely active ulcerative colitis.一项多中心回顾性研究旨在确定中度至重度活动溃疡性结肠炎患者中对吸附性粒单细胞去除治疗反应良好的患者。
Clin Transl Gastroenterol. 2018 Jul 6;9(7):170. doi: 10.1038/s41424-018-0037-0.
4
Granulo-monocyto apheresis is more effective in mild ulcerative colitis than in moderate to severe disease.粒-单核细胞分离术对轻度溃疡性结肠炎的疗效比对中度至重度疾病的疗效更好。
World J Gastroenterol. 2014 Dec 7;20(45):17155-62. doi: 10.3748/wjg.v20.i45.17155.
5
Leukocytapheresis for steroid-dependent ulcerative colitis in clinical practice: results of a nationwide Spanish registry.白细胞吸附疗法治疗临床实践中类固醇依赖型溃疡性结肠炎:一项全国性西班牙注册研究结果。
J Gastroenterol. 2012 Apr;47(4):359-65. doi: 10.1007/s00535-011-0499-2. Epub 2011 Nov 23.

本文引用的文献

1
Clinical effectiveness of selective granulocyte, monocyte adsorptive apheresis with the Adacolumn device in ulcerative colitis.溃疡性结肠炎应用 Adacolumn 装置选择性粒细胞、单核细胞吸附疗法的临床疗效。
Dig Dis Sci. 2010 May;55(5):1421-8. doi: 10.1007/s10620-009-0845-x. Epub 2009 Jun 11.
2
Comparison of the efficacy of granulocyte and monocyte/macrophage adsorptive apheresis and leukocytapheresis in active ulcerative colitis patients: a prospective randomized study.粒细胞和单核细胞/巨噬细胞吸附性血液成分单采术与白细胞去除术治疗活动期溃疡性结肠炎患者的疗效比较:一项前瞻性随机研究。
Eur J Gastroenterol Hepatol. 2008 Jul;20(7):629-33. doi: 10.1097/MEG.0b013e3282f5e9a4.
3
Leucocytapheresis for inflammatory bowel disease in the era of biologic therapy.生物治疗时代炎症性肠病的白细胞去除术
Eur J Gastroenterol Hepatol. 2008 Jul;20(7):596-600. doi: 10.1097/MEG.0b013e3282f5e9f3.
4
A randomized, double-blind, sham-controlled study of granulocyte/monocyte apheresis for active ulcerative colitis.一项关于粒细胞/单核细胞单采术治疗活动性溃疡性结肠炎的随机、双盲、假对照研究。
Gastroenterology. 2008 Aug;135(2):400-9. doi: 10.1053/j.gastro.2008.04.023. Epub 2008 Apr 25.
5
Leukocytapheresis as promising therapy for inflammatory bowel disease.
Dig Liver Dis. 2007 May;39(5):435-7. doi: 10.1016/j.dld.2007.02.003. Epub 2007 Mar 26.
6
Predictive factors of efficacy of leukocytapheresis for steroid-resistant ulcerative colitis patients.白细胞去除术对激素抵抗型溃疡性结肠炎患者疗效的预测因素
Dig Liver Dis. 2007 May;39(5):422-9. doi: 10.1016/j.dld.2007.01.010. Epub 2007 Mar 26.
7
Meta-analysis of risk of malignancy with immunosuppressive drugs in inflammatory bowel disease.炎症性肠病中免疫抑制药物所致恶性肿瘤风险的Meta分析。
Ann Pharmacother. 2007 Jan;41(1):21-8. doi: 10.1345/aph.1H219. Epub 2007 Jan 2.
8
Positions of selective leukocytapheresis in the medical therapy of ulcerative colitis.选择性白细胞去除术在溃疡性结肠炎医学治疗中的地位。
World J Gastroenterol. 2006 Dec 21;12(47):7568-77. doi: 10.3748/wjg.v12.i47.7568.
9
Activated platelets as a possible early marker to predict clinical efficacy of leukocytapheresis in severe ulcerative colitis patients.活化血小板作为预测白细胞去除术对重症溃疡性结肠炎患者临床疗效的一种可能的早期标志物。
J Gastroenterol. 2006 Jun;41(6):524-32. doi: 10.1007/s00535-006-1789-y.
10
Mucosal features and granulocyte-monocyte-apheresis in steroid-dependent/refractory ulcerative colitis.类固醇依赖/难治性溃疡性结肠炎的黏膜特征与粒细胞-单核细胞分离术
Dig Liver Dis. 2006 Jun;38(6):389-94. doi: 10.1016/j.dld.2005.12.005. Epub 2006 Mar 29.